Analyzing the options chain and the chart patterns of CLRB Cellectar Biosciences prior to the earnings report this week, I would consider purchasing the 5usd strike price in the money Puts with an expiration date of 2024-4-19, for a premium of approximately $1.15. If these options prove to be profitable prior to the earnings release, I would sell at least half of them.
Trade closed: target reached
⋅
CLRB traded at $3.04 at expiration, and the Puts went up from $1.15 (when I wrote this article) to $1.96 at the close on friday, for about 70% gain.